Annual EBITDA
-$4.61 M
-$2.02 M-77.98%
December 1, 2023
Summary
- As of February 7, 2025, LIPO annual EBITDA is -$4.61 million, with the most recent change of -$2.02 million (-77.98%) on December 1, 2023.
- During the last 3 years, LIPO annual EBITDA has fallen by -$4.55 million (-8478.03%).
- LIPO annual EBITDA is now -8478.03% below its all-time high of -$53.70 thousand, reached on December 1, 2020.
Performance
LIPO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.44 M
-$507.10 K-54.13%
September 1, 2024
Summary
- As of February 7, 2025, LIPO quarterly EBITDA is -$1.44 million, with the most recent change of -$507.10 thousand (-54.13%) on September 1, 2024.
- Over the past year, LIPO quarterly EBITDA has dropped by -$507.10 thousand (-54.13%).
- LIPO quarterly EBITDA is now -324.80% below its all-time high of -$339.90 thousand, reached on June 1, 2021.
Performance
LIPO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$4.26 M
-$121.30 K-2.93%
September 1, 2024
Summary
- As of February 7, 2025, LIPO TTM EBITDA is -$4.26 million, with the most recent change of -$121.30 thousand (-2.93%) on September 1, 2024.
- Over the past year, LIPO TTM EBITDA has dropped by -$121.30 thousand (-2.93%).
- LIPO TTM EBITDA is now -595.15% below its all-time high of -$612.90 thousand, reached on March 1, 2021.
Performance
LIPO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LIPO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.0% | -54.1% | -2.9% |
| 3 y3 years | -8478.0% | -54.1% | -2.9% |
| 5 y5 years | -8478.0% | -54.1% | -2.9% |
LIPO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.8% | at low | -302.0% | +5.8% | -129.2% | +10.0% |
| 5 y | 5-year | -8478.0% | at low | -324.8% | +5.8% | -595.1% | +10.0% |
| alltime | all time | -8478.0% | at low | -324.8% | +5.8% | -595.1% | +10.0% |
Lipella Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.44 M(+54.1%) | -$4.26 M(+2.9%) |
| Jun 2024 | - | -$936.80 K(-21.4%) | -$4.14 M(-12.6%) |
| Mar 2024 | - | -$1.19 M(+73.2%) | -$4.74 M(+2.8%) |
| Dec 2023 | -$4.61 M(+78.0%) | -$688.20 K(-48.0%) | -$4.61 M(+7.7%) |
| Sep 2023 | - | -$1.32 M(-13.7%) | -$4.28 M(+16.6%) |
| Jun 2023 | - | -$1.53 M(+44.3%) | -$3.67 M(+25.8%) |
| Mar 2023 | - | -$1.06 M(+195.8%) | -$2.91 M(+12.6%) |
| Dec 2022 | -$2.59 M | -$359.20 K(-49.6%) | -$2.59 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$712.10 K(-8.8%) | -$2.61 M(+7.8%) |
| Jun 2022 | - | -$780.40 K(+6.0%) | -$2.42 M(+22.2%) |
| Mar 2022 | - | -$736.30 K(+92.2%) | -$1.98 M(+6.6%) |
| Dec 2021 | -$1.86 M(+3361.1%) | - | - |
| Dec 2021 | - | -$383.00 K(-26.8%) | -$1.86 M(+26.0%) |
| Sep 2021 | - | -$522.90 K(+53.8%) | -$1.48 M(+54.9%) |
| Jun 2021 | - | -$339.90 K(-44.5%) | -$952.80 K(+55.5%) |
| Mar 2021 | - | -$612.90 K | -$612.90 K |
| Dec 2020 | -$53.70 K | - | - |
FAQ
- What is Lipella Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals annual EBITDA year-on-year change?
- What is Lipella Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Lipella Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals TTM EBITDA year-on-year change?
What is Lipella Pharmaceuticals annual EBITDA?
The current annual EBITDA of LIPO is -$4.61 M
What is the all time high annual EBITDA for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high annual EBITDA is -$53.70 K
What is Lipella Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, LIPO annual EBITDA has changed by -$2.02 M (-77.98%)
What is Lipella Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of LIPO is -$1.44 M
What is the all time high quarterly EBITDA for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high quarterly EBITDA is -$339.90 K
What is Lipella Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, LIPO quarterly EBITDA has changed by -$507.10 K (-54.13%)
What is Lipella Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of LIPO is -$4.26 M
What is the all time high TTM EBITDA for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high TTM EBITDA is -$612.90 K
What is Lipella Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, LIPO TTM EBITDA has changed by -$121.30 K (-2.93%)